PMA device
Brio Neurostimulation System
Abbott Medical · Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY, Class III) · First FDA decision Jun 12, 2015, newest Oct 8, 2024Essential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Brio Neurostimulation"
MAUDE reports
0
Brand "Brio Neurostimulation", since 2015
PubMed studies
0
Mentioning "Brio Neurostimulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Brio Neurostimulation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Brio Neurostimulation SystemPMA supplement
P140009-S093 · Decided Oct 8, 2024 · 229 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, electrical, implanted, for parkinsonian tremor (MHY) · Neurology & Neurosurgery
- Brio Neurostimulation SystemPMA supplement
P140009-S047 · Decided Jul 15, 2019 · 69 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, electrical, implanted, for parkinsonian tremor (MHY) · Neurology & Neurosurgery
P140009 · Decided Jun 12, 2015 · 403 days after receipt
Device type: Stimulator, electrical, implanted, for parkinsonian tremor (MHY) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- External Upper Limb Tremor Stimulator TherapyLocal determinationIn effectL39591CGS Administrators, LLCUpdated Feb 16, 2024
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Brio Neurostimulation", any status and sponsor, newest update first.
No registered device study names "Brio Neurostimulation".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Brio Neurostimulation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MHY
39,013 reports: 20,330 malfunction, 18,367 injury, 312 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0459-2026 · Started Oct 6, 2025 · Posted by FDA Nov 7, 2025
Reason given: There is a potential issue affecting Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generators (IPGs), Model 32400 and Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs), Model 62400 . These devicess may experience a loss of communication with the Clinician Programmer (CP) and/or the...
Cause as FDA categorized it: Process control · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Z-2693-2017 · Started Jun 2, 2017
Reason given: The firm discovered a risk of loss of Neuromodulation therapy due to exposure of the IPG to monopolar electrosurgical devices (ESU) during medical procedures.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Z-2694-2017 · Started Jun 2, 2017
Reason given: The firm discovered a risk of loss of Neuromodulation therapy due to exposure of the IPG to monopolar electrosurgical devices (ESU) during medical procedures.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Brio Neurostimulation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MHY.
- Activa Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2025
- Activa and Percept Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2024
- Infinity family of DBS IPGsAbbott Medical · PMA 2021
- Medtronic Activa Tremor Control SystemMedtronic, Inc. · PMA 2023
- Deep Brain Stimulation (DBS) Neurostimulation SystemAbbott Medical · PMA 2025
- Deep Brain Stimulation (DBS) Therapy for EpilepsyMedtronic, Inc. · PMA 2019
- Liberta RC DBS IPGAbbott Medical · PMA 2025
- Activa, Percept and SenSight Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.